Tomas Landh is since Nov 2014 R&D Innovation Sourcing VP. He was previously Director Strategy and Innovation Sourcing at Novo Nordisk, Diabetes Research. Tomas joined Novo Nordisk in 2003.

Tomas is currently responsible for the scouting and coordination of evaluation of external innovation regarding all aspects of diabetes. In addition, he works closely with the teams responsible for assessing innovation in the other therapy areas of Novo Nordisk, obesity, NASH, CVD and haemophilia. Besides innovative therapies, the Innovation Sourcing team sources and evaluate a broad range of technologies, including new drug delivery systems and protein engineering means. Tomas is also involved in developing new strategic modes of accessing innovation in general.

Tomas has more than 25 years of experience of all stages of drug development, from academia, small businesses, foundations and big pharma/biotech. He received his PhD in Biophysical Engineering from Lund’s Institute of Technology. Tomas is currently an international advisor to LARTA/ NIH- and NSF-CAP programs.